Propranolol Dose Escalation in Lymphedema in Patients
Status:
Terminated
Trial end date:
2020-10-08
Target enrollment:
Participant gender:
Summary
This is a study to investigate the safety and efficacy of propranolol in the treatment of
patients with primary lymphedema. The primary goal is to assess patient tolerability of
increasing doses of propranolol. The secondary goal is to assess lymphedema symptoms and
signs in response to propranolol treatment.